Proteomic Differences in Blood Plasma Associated with Antidepressant Treatment Response.

about

Proteomic Differences in Blood Plasma Associated with Antidepressant Treatment Response.

Item

http://www.wikidata.org/entity/Q41605632

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Proteomic Differences in Blood Plasma Associated with Antidepressant Treatment Response.

@en

type

Item

label

Proteomic Differences in Blood Plasma Associated with Antidepressant Treatment Response.

@en

prefLabel

Proteomic Differences in Blood Plasma Associated with Antidepressant Treatment Response.

@en

P1476

Proteomic Differences in Blood Plasma Associated with Antidepressant Treatment Response.

@en

P2093

Christoph W Turck

http://www.w3.org/2001/XMLSchema#string

Daniel Martins-de-Souza

http://www.w3.org/2001/XMLSchema#string

Giuseppina Maccarrone

http://www.w3.org/2001/XMLSchema#string

Marcus Ising

http://www.w3.org/2001/XMLSchema#string

Paul C Guest

http://www.w3.org/2001/XMLSchema#string

Susanne Lucae

http://www.w3.org/2001/XMLSchema#string

P2860

A rating scale for depression

Making Sense of Blood-Based Proteomics and Metabolomics in Psychiatric Research

The Extrinsic Coagulation Pathway: a Biomarker for Suicidal Behavior in Major Depressive Disorder.

Identification of blood-based molecular signatures for prediction of response and relapse in schizophrenia patients

Feasibility of investigating differential proteomic expression in depression: implications for biomarker development in mood disorders.

A review of the relationship between proinflammatory cytokines and major depressive disorder.

Cross-national epidemiology of DSM-IV major depressive episode.

Evidence for disturbed insulin and growth hormone signaling as potential risk factors in the development of schizophrenia

Development of a blood-based molecular biomarker test for identification of schizophrenia before disease onset

Discovery and validation of plasma biomarkers for major depressive disorder classification based on liquid chromatography-mass spectrometry.

P304

272

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3389/FNMOL.2017.00272

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Florian Holsboer

Stefan Kloiber

P577

2017-08-31T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28912679

http://www.w3.org/2001/XMLSchema#string

P932

5583163

http://www.w3.org/2001/XMLSchema#string